ALBT vs LRHC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ALBT exhibits severe financial distress, as evidenced by a Piotroski F-Score of 1/9, indicating extreme weakness in operational and financial health. The company reports a negative ROE of -4,129.79% and a negative Price/Book ratio of -0.17, signaling deep losses and asset erosion. With no meaningful profitability, negative cash flow indicators, and a current ratio of just 0.15, liquidity and solvency are critically impaired. The stock has declined over 99% in five years, reflecting sustained investor pessimism. Despite a modest gross margin of 35.65%, the company’s inability to generate sustainable earnings or positive cash flow undermines any potential for recovery.
LRHC exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a catastrophic 1-year price collapse of 99.7%. While the Price-to-Book (0.03) and Price-to-Sales (0.02) ratios appear superficially cheap, they are classic indicators of a value trap given the company's negative profit margins (-35.48%) and an abysmal ROE of -345.32%. The technical trend is completely bearish (0/100), and the lack of an Altman Z-Score or Graham Number suggests insufficient positive earnings or stability to support a valuation model. The company is currently in a state of freefall with no fundamental catalysts for recovery.
Compare Another Pair
Related Comparisons
ALBT vs LRHC: Head-to-Head Comparison
This page compares Avalon GloboCare Corp. (ALBT) and La Rosa Holdings Corp. (LRHC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.